Effect of mulberry (Morus indica L.) therapy on plasma and erythrocyte membrane lipids in patients with type 2 diabetes (Q43805967)

27 November 2017

title

Effect of mulberry (Morus indica L.) therapy on plasma and erythrocyte membrane lipids in patients with type 2 diabetes (English)

1 reference

27 November 2017

0 references

1 reference

Andallu B

1

1 reference

27 November 2017

Suryakantham V

series ordinal

2

1 reference

27 November 2017

Lakshmi Srikanthi B

series ordinal

3

1 reference

27 November 2017

Reddy GK

series ordinal

4

1 reference

27 November 2017

publication date

1 December 2001

1 reference

27 November 2017

1 reference

27 November 2017

volume

314

1 reference

27 November 2017

issue

1-2

1 reference

27 November 2017

page(s)

47-53

1 reference

Simvastatin treatment on postprandial hypertriglyceridemia in type 2 diabetes mellitus patients with combined hyperlipidemia

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). UK Prospective Diabetes Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Effect of insulin treatment on fatty acids of plasma and erythrocyte membrane lipids in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Diabetes increases excretion of urinary malonaldehyde conjugates in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Changes in phospholipid composition of blood cell membranes (erythrocyte, platelet, and polymorphonuclear) in different types of diabetes--clinical and biological correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Fatty acid composition of serum lipids and erythrocyte membranes in type 2 (non-insulin-dependent) diabetic men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Evaluation of the anti-diabetic property of Morinda lucida leaves in streptozotocin-diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

NOVEL LIPID-LOWERING PROPERTIES OF VACCINIUM MYRTILLUS L. LEAVES, A TRADITIONAL ANTIDIABETIC TREATMENT, IN SEVERAL MODELS OF RAT DYSLIPIDAEMIA: A COMPARISON WITH CIPROFIBRATE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Natural products and diabetes treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Potentiating effects on pilocarpine-induced saliva secretion, by extracts and N-containing sugars derived from mulberry leaves, in streptozocin-diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Hypoglycemic Activity and Mechanisms of Extracts from Mulberry Leaves (Folium Mori) and Cortex Mori Radicis in Streptozotocin-Induced Diabetic Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Colorimetric measurement of glycosylated protein in whole blood, red blood cells, plasma and dried blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Microsomal lipid peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Matching treatment to pathophysiology in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Potentiation of glucose-induced insulin secretion by fagomine, a pseudo-sugar isolated from mulberry leaves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

Mulberry leaf extract inhibits the oxidative modification of rabbit and human low density lipoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900632-5

10.1016/S0009-8981(01)00632-5

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference